ArticleKidney international reports2026
Dual Burden of Kidney Disease and Cognitive Impairment in the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia-Cohort.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic kidney disease (CKD) and cognitive impairment are being increasingly recognized as major public health challenges in aging populations, yet their interrelationship remains underexplored in India. Methods: Data from Longitudinal Aging Study in India- Diagnostic Assessment of Dementia (LASI-DAD) cohort was analyzed. Estimated glomerular filtration rate (eGFR) was estimated using serum creatinine, cystatin C, and combined CKD-Epidemiology Collaboration (CKD-EPI) equations. Cognitive performance was assessed using Hindi Mental State Examination (HMSE) and domain-specific cognitive tests. Results: The prevalence of eGFR <60 ml/min per 1.73 m Conclusion: No significant association between eGFR and cognition was found in the LASI-DAD cohort. High prevalence of reduced eGFR and cognitive impairment may be attributed to age, modifiable risk factors, and region-specific differences, highlighting the need for further longitudinal research in low- and middle-income countries (LMICs).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.